Main Industry
Biotechnology
Main Product/Service
Utilizing genetic simulation technology and AI big data to perform simulated predictions of genetic and symptom likelihoods.
(The content above was translated by AI.)
(The content above was translated by AI.)
Founded Year
2018
Unified Business No.
50861926
Status
Closed
Number of Employees
0
Total Paid-in
Capital
33,000,000 (NT$)
Location of Company
Taiwan
, Taichung City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Through the concept of precision medicine, treatment methods and the use of medication can be made more precise. Its main essence is to accurately understand the occurrence and progression of diseases. By effectively exploring the causes and effects of diseases, and combining medical scientific research with cross-disciplinary technologies, the prevention, diagnosis, and treatment of diseases can be made more precise.
(The content above was translated by AI.)
(The content above was translated by AI.)
